CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 48 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $29,000 | -80.5% | 10,205 | -79.3% | 0.00% | – |
| Q1 2021 | $149,000 | -5.1% | 49,220 | -7.9% | 0.00% | – |
| Q4 2020 | $157,000 | -8.7% | 53,441 | 0.0% | 0.00% | – |
| Q3 2020 | $172,000 | -3.4% | 53,441 | 0.0% | 0.00% | – |
| Q2 2020 | $178,000 | -8.2% | 53,441 | 0.0% | 0.00% | – |
| Q1 2020 | $194,000 | -30.0% | 53,441 | -0.7% | 0.00% | – |
| Q4 2019 | $277,000 | -13.2% | 53,800 | 0.0% | 0.00% | – |
| Q3 2019 | $319,000 | -7.0% | 53,800 | 0.0% | 0.00% | – |
| Q2 2019 | $343,000 | +9.6% | 53,800 | 0.0% | 0.00% | – |
| Q1 2019 | $313,000 | -7.7% | 53,800 | 0.0% | 0.00% | – |
| Q4 2018 | $339,000 | +10.4% | 53,800 | 0.0% | 0.00% | – |
| Q3 2018 | $307,000 | -7.0% | 53,800 | 0.0% | 0.00% | – |
| Q2 2018 | $330,000 | -8.1% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $359,000 | -10.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $399,000 | +5.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $380,000 | 0.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $380,000 | +1.9% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $373,000 | +26.0% | 53,800 | 0.0% | 0.00% | – |
| Q4 2016 | $296,000 | +9.6% | 53,800 | 0.0% | 0.00% | – |
| Q3 2016 | $270,000 | +11.6% | 53,800 | 0.0% | 0.00% | – |
| Q2 2016 | $242,000 | 0.0% | 53,800 | 0.0% | 0.00% | – |
| Q1 2016 | $242,000 | -14.5% | 53,800 | 0.0% | 0.00% | – |
| Q4 2015 | $283,000 | -8.7% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $310,000 | -19.5% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $385,000 | +19.6% | 53,800 | 0.0% | 0.00% | – |
| Q1 2015 | $322,000 | 0.0% | 53,800 | 0.0% | 0.00% | – |
| Q4 2014 | $322,000 | +21.1% | 53,800 | 0.0% | 0.00% | – |
| Q3 2014 | $266,000 | +9.9% | 53,800 | 0.0% | 0.00% | – |
| Q2 2014 | $242,000 | +0.8% | 53,800 | 0.0% | 0.00% | – |
| Q1 2014 | $240,000 | -50.1% | 53,800 | -42.2% | 0.00% | -100.0% |
| Q4 2013 | $481,000 | +13.2% | 93,100 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $425,000 | -11.3% | 93,800 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $479,000 | – | 93,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |